Nafcillin

Product NDC: 25021-198
11-digit product format: 250210198
Labeler code: 25021
Product ID: 25021-198_f50e7f65-8bca-4df1-bff1-8069b33def90
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Nafcillin Sodium
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Labeler: Sagent Pharmaceuticals
Application: ANDA090005
Marketing category: ANDA
Marketing start: 2025-04-15
Substance: NAFCILLIN SODIUM
Active strength: 10 g/100mL
Pharmacologic classes: Penicillin-class Antibacterial [EPC], Penicillins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

openFDA Listing Details

Product ID: 25021-198_f50e7f65-8bca-4df1-bff1-8069b33def90
SPL ID: f50e7f65-8bca-4df1-bff1-8069b33def90
Product type: HUMAN PRESCRIPTION DRUG
Finished product: Yes
Brand name base: Nafcillin
Generic name: Nafcillin Sodium
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Marketing start: 2025-04-15
Marketing category: ANDA
Application number: ANDA090005
Pharmacologic classes: Penicillin-class Antibacterial [EPC]; Penicillins [CS]
Listing expiration: 2026-12-31

Ingredient	Strength
NAFCILLIN SODIUM	10 g/100mL

Package NDC	Description	Marketing start	Sample
25021-198-99	1 VIAL in 1 CARTON (25021-198-99) / 100 mL in 1 VIAL	2025-04-15	No

UNII	Preferred term	Registry number	Matched term
49G3001BCK	NAFCILLIN SODIUM	7177-50-6	NAFCILLIN SODIUM

Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
25021-198-99	25021019899	1 VIAL in 1 CARTON (25021-198-99) / 100 mL in 1 VIAL	1 vial	2025-04-15	No	No	Historical

Title	Manufacturer	Effective date	Type	Version
Nafcillin for Injection, USP	Sagent Pharmaceuticals	2025-04-27	HUMAN PRESCRIPTION DRUG LABEL	1